{
    "organizations": [],
    "uuid": "ab3170651cec0be8ff3b37b12579909ce70b1712",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nestl-skin-health-announces-fda-ap/brief-nestl-skin-health-announces-fda-approval-of-restylane-lyft-for-correction-of-age-related-volume-loss-in-back-of-hands-idUSASC0A31F",
    "ord_in_thread": 0,
    "title": "Nestlé Skin Health Announces FDA Approval Of Restylane Lyft For Correction Of Age-Related Volume Loss In Back Of Hands",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 21 (Reuters) - Nestle SA:\n* NESTLÉ SKIN HEALTH ANNOUNCES THE FDA APPROVAL OF RESTYLANE® LYFT FOR HANDS, THE FIRST AND ONLY HYALURONIC ACID (HA) DERMAL FILLER FOR USE IN THE BACK OF HANDS\n* NESTLÉ SKIN HEALTH - U.S. FDA APPROVED RESTYLANE LYFT FOR CORRECTION OF AGE-RELATED VOLUME LOSS IN BACK OF HANDS FOR PATIENTS OVER AGE OF 21 Source text for Eikon: ",
    "published": "2018-05-21T21:08:00.000+03:00",
    "crawled": "2018-05-21T16:13:28.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "nestle",
        "sa",
        "nestlé",
        "skin",
        "health",
        "announces",
        "fda",
        "approval",
        "lyft",
        "hand",
        "first",
        "hyaluronic",
        "acid",
        "ha",
        "dermal",
        "filler",
        "use",
        "back",
        "hand",
        "nestlé",
        "skin",
        "health",
        "fda",
        "approved",
        "restylane",
        "lyft",
        "correction",
        "volume",
        "loss",
        "back",
        "hand",
        "patient",
        "age",
        "source",
        "text",
        "eikon"
    ]
}